We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Analysis of Chromosome 7 Reveals Structures Linked to Diseases

By Biotechdaily staff writers
Posted on 16 Jul 2003
A team of researchers from six institutions has sequenced 99.4% of chromosome 7, which has led to the discovery of structural features that appear to promote disease-causing genetic changes. More...
The sequencing was reported in the July 10, 2003, issue of Nature.

Chromosome 7 is the largest chromosome sequenced to date. Previously, genome mapping techniques were developed on the chromosome, and it was the first chromosome to be searched by positional cloning in a successful hunt for the cystic fibrosis gene. During the current sequencing of the chromosome, researchers found that it contains an unusually high amount of duplicated sequence segments, and this duplication is much more extensive on the short arm of the chromosome. The reason for this remains unknown, although the researchers note that it may encourage the type of genetic deletions that cause disease.

This appears to be the case in Williams-Beuren syndrome, which is characterized by growth deficiency, heart disorders, and mild retardation. The syndrome is linked to very large deletions in a region of the long arm, which the new analysis shows to be a hotbed of duplicated segments. Such rearrangements of genetic material may occasionally help new genes to form, however. In all, about 1,150 protein-encoding genes were found on chromosome 7, about 20% less than predicted in a previous study by another team.

"Besides containing many genes that are crucial to development, this chromosome also hold the gene for cystic fibrosis and is frequently damaged in some types of leukemia and other cancers,” said Francis S. Collins, M.D., Ph.D., director of the US National Human Genome Research Institute (NHGRI, USA), which funded the study and also participated in the research. "This new analysis, coupled with our commitment to free and unrestricted access to sequence data, should further speed the discovery of genes on chromosome 7 related to human health and diseases.”




Related Links:
S National Human Genome Research Institute

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Electrolyte Analyzer
BKE-B
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.